Azienda Ospedaliera Universitaria Integrata Verona
In research, Azienda Ospedaliera Universitaria Integrata Verona stands highest in Medicine (#1,907 of 10,443 worldwide) and Health Sciences (#2,371 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 8.6× its share of world research.
- World rank, 2022–2025
- #6,500 of 28,054 · #9,062 all time
- Rank in Italy
- #187 of 618
- Research works
- 1.7k ▲ 23% vs 2013–17
- Citations
- 36k 21.5 per fractional work
- Top-10% rate
- 18.9% record average 16.5%
- Open access
- 46% world 28%
What is Azienda Ospedaliera Universitaria Integrata Verona known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,907 of 10,443 | 18.1% | 339 | #2140 | |
| Health SciencesDomain | #2,371 of 11,982 | 18.2% | 351 | #2578 |
Each strip is that field’s whole ranked pool, with the notch where Azienda Ospedaliera Universitaria Integrata Verona sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Azienda Ospedaliera Universitaria Integrata Verona specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 8.6× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 55.9 works8.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.
- Medicine 4.2×
- Immunology and Microbiology 1.6×
- Biochemistry, Genetics and Molecular Biology 1.3×
- Nursing 1.1×
- Neuroscience 0.8×
- Health Professions 0.7×
- Psychology 0.6×
- Pharmacology, Toxicology and Pharmaceutics 0.5×
- Dentistry 0.4×
- Economics, Econometrics and Finance 0.3×
- Physics and Astronomy 0.3×
- Veterinary 0.2×
- Decision Sciences 0.1×
- Arts and Humanities 0.1×
- Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Materials Science 0.1×
- Mathematics 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Energy 0.0×
- Business, Management and Accounting 0.0×
- Chemistry 0.0×
Who are the top researchers at Azienda Ospedaliera Universitaria Integrata Verona?
Ranked on the composite score, Gloria Tridello, Simone Cesaro and Alessandro Mantovani lead among researchers whose main affiliation is Azienda Ospedaliera Universitaria Integrata Verona.
- 1 Gloria Tridello Italy · #410,867 worldwide 57 citations · 30 works
- 2 Simone Cesaro Italy · #458,103 worldwide 187 citations · 94 works
- 3 Alessandro Mantovani Italy · #462,878 worldwide 116 citations · 36 works
- 4 Marco Cipolli Italy · #511,480 worldwide 34 citations · 21 works
- 5 Mirko Zoncapè Italy · #768,679 worldwide 15 citations · 21 works
- 6 Giulia Zamboni Italy · #848,046 worldwide 14 citations · 28 works
- 7 Paolo Biban Italy · #866,541 worldwide 31 citations · 30 works
- 8 Sergio Maluta Italy · #869,192 worldwide 21 citations · 20 works
- 9 Giovanni Paolo Pollini Italy · #915,789 worldwide 20 citations · 34 works
- 10 Stefania Montemezzi Italy · #918,734 worldwide 9 citations · 20 works
Which keywords describe research at Azienda Ospedaliera Universitaria Integrata Verona?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Immunotherapy, Chemotherapy, Metabolic Syndrome, Genetic Mutations, Diagnosis, Treatment and Inflammation.
- Screening
- MRI Imaging
- Survival Rates
- NAFLD
- Bronchiectasis
- Rehabilitation
- Genetic Variants
- Radiation Therapy
- Cystic Fibrosis
- Surgery
- Mutation Analysis
- Hepatocellular Carcinoma
- Prognostic Factors
- Urinary Incontinence
- Insulin Resistance
- Quality of Life
- Cardiovascular Disease
- Treatment
- Chemotherapy
- Inflammation
- Epidemiology
- Immunotherapy
- Metabolic Syndrome
- Diagnosis
- Genetic Mutations
- Clinical Guidelines
- Management
- Guidelines
- Prostate Cancer
- Clinical Trials
- Neoadjuvant Therapy
- Molecular Characterization
- Hepatic Steatosis
- Microbiota
- Heart Failure
- Pulmonary Infections
- CFTR
- NASH
- Hypertension
- Biopsy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology55▲ 3.3×93 topics
- Inflammation26▲ 3.0×61 topics
- Immunotherapy24▲ 8.2×18 topics
- Chemotherapy22▲ 7.5×22 topics
- Metabolic Syndrome22▲ 6.4×18 topics
- Treatment22▲ 4.2×33 topics
- Diagnosis21▲ 5.4×33 topics
- Cardiovascular Disease21▲ 4.4×27 topics
- Genetic Mutations18▲ 10×19 topics
- Quality of Life17▲ 2.9×26 topics
- Clinical Guidelines16▲ 13×8 topics
- Insulin Resistance15▲ 8.0×9 topics
- Management14▲ 4.3×23 topics
- Urinary Incontinence14▲ 43×2 topics
- Guidelines14▲ 6.9×13 topics
- Prognostic Factors14▲ 7.4×14 topics
- Prostate Cancer14▲ 25×5 topics
- Hepatocellular Carcinoma12▲ 14×3 topics
- Clinical Trials12▲ 4.3×11 topics
- Mutation Analysis12▲ 38×2 topics
- Neoadjuvant Therapy12▲ 12×5 topics
- Surgery12▲ 7.8×10 topics
- Molecular Characterization11▲ 15×6 topics
- Cystic Fibrosis11▲ 36×3 topics
- Hepatic Steatosis11▲ 16×2 topics
- Radiation Therapy10▲ 19×6 topics
- Microbiota10▲ 11×2 topics
- Genetic Variants10▲ 14×7 topics
- Heart Failure10▲ 5.6×12 topics
- Rehabilitation10▲ 6.1×6 topics
- Pulmonary Infections10▲ 42×2 topics
- Bronchiectasis10▲ 81×1 topic
- CFTR10▲ 81×1 topic
- NAFLD10▲ 19×1 topic
- NASH10▲ 19×1 topic
- Survival Rates10▲ 24×2 topics
- Hypertension9▲ 7.6×11 topics
- MRI Imaging9▲ 26×4 topics
- Biopsy9▲ 34×2 topics
- Screening8▲ 21×2 topics
Which research topics does Azienda Ospedaliera Universitaria Integrata Verona publish most on?
By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Cystic Fibrosis Research Advances, Prostate Cancer Diagnosis and Treatment and Pelvic floor disorders treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease Diagnosis and Treatment Epidemiology 10 works
- 2 Cystic Fibrosis Research Advances Pulmonary and Respiratory Medicine 10 works
- 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 8 works
- 4 Pelvic floor disorders treatments Rheumatology 8 works
- 5 Urinary Bladder and Prostate Research Urology 6 works
- 6 Bladder and Urothelial Cancer Treatments Surgery 5 works
- 7 Liver Disease and Transplantation Hepatology 5 works
- 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 5 works
- 9 Pancreatic and Hepatic Oncology Research Oncology 4 works
- 10 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Azienda Ospedaliera Universitaria Integrata Verona's research output changed?
Output in 2018–2022 was 23% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Verona
- University of Verona
- GlaxoSmithKline (Italy)
- Cystic Fibrosis Research Foundation
- Aptuit (Italy)
- EDALab (Italy)
- Audi (Italy)
- ICI Caldaie (Italy)
- STM Products (Italy)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.